Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Genenta Science S.p.A. Unsponsored ADR (GNTA) had Stock-Based Compensation of $0.48M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$23.83M |
|
$0.04M |
|
$0.63M |
|
$24.47M |
|
$1.81M |
|
$8.58M |
|
$8.91M |
|
$10.72M |
|
$13.75M |
|
$13.75M |
|
$13.75M |
|
19.15M |
|
| Cash Flow Statement Financials | |
$-6.26M |
|
$-5.04M |
|
$11.89M |
|
$5.20M |
|
$5.88M |
|
$0.68M |
|
|
Stock-Based Compensation |
$0.48M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|